JP Stock MarketDetailed Quotes

Kyorin Pharmaceutical (4569)

Watchlist
  • 1404
  • +31+2.26%
20min DelayNot Open May 14 15:30 JST
84.16BMarket Cap8.88P/E (Static)

Kyorin Pharmaceutical (4569) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
Total revenue
33.73B
6.37%30.23B
8.83%130.09B
2.03%28.42B
5.53%119.53B
32.27B
2.26%32.33B
10.66%27.08B
13.14%27.85B
7.33%113.27B
Cost of revenue
19.09B
5.61%16.97B
3.90%70.55B
2.86%16.07B
7.61%67.9B
18.95B
10.40%17.85B
11.36%15.48B
15.03%15.62B
12.50%63.1B
Gross profit
14.64B
7.37%13.26B
15.32%59.54B
0.97%12.35B
2.91%51.63B
13.31B
-6.25%14.48B
9.76%11.6B
10.81%12.23B
1.47%50.17B
Operating expense
11.39B
-2.76%10.89B
3.47%46.97B
-2.78%11.2B
0.78%45.39B
11.55B
-1.48%11.35B
6.76%10.98B
9.21%11.52B
1.37%45.04B
Operating profit
3.25B
106.00%2.37B
101.60%12.57B
61.74%1.15B
21.66%6.23B
1.77B
-20.25%3.13B
117.01%625M
45.10%711M
2.32%5.12B
Net non-operating interest income (expenses)
-59M
-255.56%-64M
-588.00%-172M
-200.00%-18M
46.81%-25M
-10M
108.33%1M
33.33%-10M
64.71%-6M
26.56%-47M
Non-operating interest income
--0
--0
-97.56%1M
--0
115.79%41M
--7M
325.00%17M
250.00%7M
--10M
850.00%19M
Non-operating interest expense
--59M
255.56%64M
162.12%173M
12.50%18M
0.00%66M
--17M
0.00%16M
0.00%17M
-5.88%16M
0.00%66M
Net investment income
293M
43.90%295M
27.61%661M
-8.07%205M
-1.15%518M
-8M
16.14%259M
-16.98%44M
-21.75%223M
3.56%524M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
0
0
-130.72%-305M
0
47.11%993M
2M
2,300.00%22M
310.94%675M
Income from associates and other participating interests
25M
120.00%11M
416.67%38M
135.71%5M
-12M
-16M
400.00%20M
71.43%-2M
-600.00%-14M
0
Special income (charges)
-23M
186.44%102M
65.55%-164M
-3,833.33%-118M
-199.79%-476M
425M
-5,826.67%-889M
96.70%-9M
-100.34%-3M
1,425.00%477M
Less:Impairment of capital assets
--3M
-66.67%2M
175.00%22M
200.00%6M
100.00%8M
--2M
100.00%2M
100.00%2M
100.00%2M
0.00%4M
Less:Other special charges
--20M
-192.86%-104M
-69.66%142M
11,100.00%112M
163.41%468M
---427M
8,770.00%887M
-95.91%7M
100.11%1M
-2,406.25%-738M
Less:Write off
--0
----
----
----
--0
--0
----
----
----
--257M
Other non-operating income (expenses)
11M
-80.49%16M
1,985.71%146M
1,540.00%82M
-95.51%7M
-70M
164.00%66M
-92.00%6M
-78.26%5M
60.82%156M
Income before tax
3.5B
109.04%2.73B
76.41%12.77B
42.94%1.31B
4.82%7.24B
2.09B
-37.09%2.61B
956.49%1.63B
-44.93%913M
32.40%6.91B
Income tax
869M
49.88%628M
108.84%3.68B
77.54%419M
-19.16%1.76B
529M
-42.21%586M
334.74%413M
-50.21%236M
69.94%2.18B
Net income
2.63B
137.29%2.1B
65.95%9.09B
30.92%885M
15.92%5.48B
1.56B
-35.44%2.02B
1,957.63%1.21B
-42.86%676M
20.12%4.72B
Net income continuous operations
--2.63B
137.02%2.1B
65.95%9.09B
30.87%886M
15.90%5.48B
--1.56B
-35.44%2.02B
1,957.63%1.21B
-42.82%677M
20.14%4.72B
Noncontrolling interests
Net income attributable to the company
2.63B
137.29%2.1B
65.95%9.09B
30.92%885M
15.92%5.48B
1.56B
-35.44%2.02B
1,957.63%1.21B
-42.86%676M
20.12%4.72B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
2.63B
137.29%2.1B
65.95%9.09B
30.92%885M
15.92%5.48B
1.56B
-35.44%2.02B
1,957.63%1.21B
-42.86%676M
20.12%4.72B
Gross dividend payment
Basic earnings per share
45.7
137.16%36.57
65.78%158.17
30.57%15.42
15.73%95.41
27.18
-35.55%35.26
1,934.62%21.16
-42.81%11.81
20.14%82.44
Diluted earnings per share
45.6906
137.16%36.57
65.78%158.17
30.57%15.42
15.73%95.41
27.172
-35.60%35.2314
1,955.10%21.16
-42.81%11.81
20.14%82.44
Dividend per share
0
0
0.00%52
0
0.00%52
32
0
0.00%20
0
0.00%52
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Dec 31, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023
Total revenue 33.73B6.37%30.23B8.83%130.09B2.03%28.42B5.53%119.53B32.27B2.26%32.33B10.66%27.08B13.14%27.85B7.33%113.27B
Cost of revenue 19.09B5.61%16.97B3.90%70.55B2.86%16.07B7.61%67.9B18.95B10.40%17.85B11.36%15.48B15.03%15.62B12.50%63.1B
Gross profit 14.64B7.37%13.26B15.32%59.54B0.97%12.35B2.91%51.63B13.31B-6.25%14.48B9.76%11.6B10.81%12.23B1.47%50.17B
Operating expense 11.39B-2.76%10.89B3.47%46.97B-2.78%11.2B0.78%45.39B11.55B-1.48%11.35B6.76%10.98B9.21%11.52B1.37%45.04B
Operating profit 3.25B106.00%2.37B101.60%12.57B61.74%1.15B21.66%6.23B1.77B-20.25%3.13B117.01%625M45.10%711M2.32%5.12B
Net non-operating interest income (expenses) -59M-255.56%-64M-588.00%-172M-200.00%-18M46.81%-25M-10M108.33%1M33.33%-10M64.71%-6M26.56%-47M
Non-operating interest income --0--0-97.56%1M--0115.79%41M--7M325.00%17M250.00%7M--10M850.00%19M
Non-operating interest expense --59M255.56%64M162.12%173M12.50%18M0.00%66M--17M0.00%16M0.00%17M-5.88%16M0.00%66M
Net investment income 293M43.90%295M27.61%661M-8.07%205M-1.15%518M-8M16.14%259M-16.98%44M-21.75%223M3.56%524M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets 00-130.72%-305M047.11%993M2M2,300.00%22M310.94%675M
Income from associates and other participating interests 25M120.00%11M416.67%38M135.71%5M-12M-16M400.00%20M71.43%-2M-600.00%-14M0
Special income (charges) -23M186.44%102M65.55%-164M-3,833.33%-118M-199.79%-476M425M-5,826.67%-889M96.70%-9M-100.34%-3M1,425.00%477M
Less:Impairment of capital assets --3M-66.67%2M175.00%22M200.00%6M100.00%8M--2M100.00%2M100.00%2M100.00%2M0.00%4M
Less:Other special charges --20M-192.86%-104M-69.66%142M11,100.00%112M163.41%468M---427M8,770.00%887M-95.91%7M100.11%1M-2,406.25%-738M
Less:Write off --0--------------0--0--------------257M
Other non-operating income (expenses) 11M-80.49%16M1,985.71%146M1,540.00%82M-95.51%7M-70M164.00%66M-92.00%6M-78.26%5M60.82%156M
Income before tax 3.5B109.04%2.73B76.41%12.77B42.94%1.31B4.82%7.24B2.09B-37.09%2.61B956.49%1.63B-44.93%913M32.40%6.91B
Income tax 869M49.88%628M108.84%3.68B77.54%419M-19.16%1.76B529M-42.21%586M334.74%413M-50.21%236M69.94%2.18B
Net income 2.63B137.29%2.1B65.95%9.09B30.92%885M15.92%5.48B1.56B-35.44%2.02B1,957.63%1.21B-42.86%676M20.12%4.72B
Net income continuous operations --2.63B137.02%2.1B65.95%9.09B30.87%886M15.90%5.48B--1.56B-35.44%2.02B1,957.63%1.21B-42.82%677M20.14%4.72B
Noncontrolling interests
Net income attributable to the company 2.63B137.29%2.1B65.95%9.09B30.92%885M15.92%5.48B1.56B-35.44%2.02B1,957.63%1.21B-42.86%676M20.12%4.72B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 2.63B137.29%2.1B65.95%9.09B30.92%885M15.92%5.48B1.56B-35.44%2.02B1,957.63%1.21B-42.86%676M20.12%4.72B
Gross dividend payment
Basic earnings per share 45.7137.16%36.5765.78%158.1730.57%15.4215.73%95.4127.18-35.55%35.261,934.62%21.16-42.81%11.8120.14%82.44
Diluted earnings per share 45.6906137.16%36.5765.78%158.1730.57%15.4215.73%95.4127.172-35.60%35.23141,955.10%21.16-42.81%11.8120.14%82.44
Dividend per share 000.00%5200.00%523200.00%2000.00%52
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More